245 related articles for article (PubMed ID: 7430557)
21. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer.
Pacini F; Lari R; Mazzeo S; Grasso L; Taddei D; Pinchera A
Clin Endocrinol (Oxf); 1985 Oct; 23(4):405-11. PubMed ID: 4064348
[TBL] [Abstract][Full Text] [Related]
22. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
[TBL] [Abstract][Full Text] [Related]
23. Importance of thyroglobulin levels for diagnosis and monitoring of follicular thyroid carcinoma in an adolescent with severe iodine deficiency.
Siklar Z; Ocal G; Berberoğlu M; Adiyaman P; Ergür AT; Evliyaoğlu O; Sak SD
J Pediatr Endocrinol Metab; 2006 Sep; 19(9):1175-8. PubMed ID: 17128567
[TBL] [Abstract][Full Text] [Related]
24. The effect of 131I for diagnostic purposes on serum thyroglobulin (hTg) levels in subjects with thyroidal disorders.
Van Herle AJ; Demeester-Mirkine N; Van Heuverswyn B; Dumont J
J Endocrinol Invest; 1981; 4(1):107-20. PubMed ID: 7240667
[TBL] [Abstract][Full Text] [Related]
25. Undetectable serum thyroglobulin levels in patients with medullary thyroid carcinoma after total thyroidectomy without radioiodine ablation.
Tomoda C; Miyauchi A
Thyroid; 2012 Jul; 22(7):680-2. PubMed ID: 22663550
[TBL] [Abstract][Full Text] [Related]
26. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
27. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
Wu HS; Huang WS; Liu YC; Yen RF; Shen YY; Kao CH
Anticancer Res; 2003; 23(5b):4235-8. PubMed ID: 14666632
[TBL] [Abstract][Full Text] [Related]
28. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
29. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.
Pineda JD; Lee T; Ain K; Reynolds JC; Robbins J
J Clin Endocrinol Metab; 1995 May; 80(5):1488-92. PubMed ID: 7744991
[TBL] [Abstract][Full Text] [Related]
30. Reduced serum thyroglobulin response to bovine TSH in malignant hypofunctioning solid thyroid nodules: comparison to benign nodular disease.
Leite Z; Carneiro P; Halpern A; Medeiros-Neto G
J Endocrinol Invest; 1987 Jun; 10(3):255-9. PubMed ID: 3624800
[TBL] [Abstract][Full Text] [Related]
31. Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors.
Leboeuf R; Emerick LE; Martorella AJ; Tuttle RM
Thyroid; 2007 Jun; 17(6):543-7. PubMed ID: 17614775
[TBL] [Abstract][Full Text] [Related]
32. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients.
Pacini F; Agate L; Elisei R; Capezzone M; Ceccarelli C; Lippi F; Molinaro E; Pinchera A
J Clin Endocrinol Metab; 2001 Sep; 86(9):4092-7. PubMed ID: 11549631
[TBL] [Abstract][Full Text] [Related]
33. Value of repeat stimulated thyroglobulin testing in patients with differentiated thyroid carcinoma considered to be free of disease in the first year after ablation.
Rosario PW; Furtado MS; Mineiro Filho AF; Lacerda RX; Calsolari MR
Thyroid; 2012 May; 22(5):482-6. PubMed ID: 22175271
[TBL] [Abstract][Full Text] [Related]
34. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
[TBL] [Abstract][Full Text] [Related]
36. [Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values].
Müller-Gärtner HW; Schneider C; Tempel MT
Nuklearmedizin; 1986 Oct; 25(5):194-200. PubMed ID: 3797259
[TBL] [Abstract][Full Text] [Related]
37. How to deal with undetectable and low measurable serum thyroglobulin levels in the follow-up of patients with differentiated thyroid carcinoma?
Välimäki M; Lamberg BA
Acta Endocrinol (Copenh); 1985 Dec; 110(4):487-92. PubMed ID: 4090912
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
39. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
40. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
